文献速递外周动脉疾病

慢性肢体威胁性缺血股腘病变:开放与腔内血运重建对比

Editor's Choice - Open versus Endovascular Revascularisation for Femoropopliteal Disease in Patients with Chronic Limb Threatening Ischaemia.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-02-16

Cox模型显示开放旁路联合单段大隐静脉在主要不良肢体事件或死亡、大截肢、无截肢生存等方面优于腔内治疗。

要点

  • 对于晚期股腘病变的慢性肢体威胁性缺血患者,开放旁路使用单段大隐静脉可能提供最有效的血运重建。
  • 开放旁路联合单段大隐静脉在主要不良肢体事件或死亡、大截肢等终点上优于腔内治疗。
  • 膝下病变、组织缺损、TASC分级和糖尿病是显著的协变量。

核心结论

  • 开放股腘旁路使用单段大隐静脉为晚期股腘病变的慢性肢体威胁性缺血患者提供最有效的血运重建。

主要发现

  • Cox模型显示开放旁路联合单段大隐静脉在主要不良肢体事件或死亡、大截肢、无截肢生存、任何再干预或大截肢或死亡、大再干预和任何再干预方面优于腔内治疗。
  • 开放旁路联合单段大隐静脉在主要不良肢体事件或死亡的无事件生存和无截肢生存方面优于开放旁路联合替代移植物。
  • 膝下病变、组织缺损、TASC分级和糖尿病是显著的协变量。

临床怎么用

  • 对于晚期股腘病变的慢性肢体威胁性缺血患者,优先考虑开放旁路使用单段大隐静脉作为血运重建策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Multiple options exist for the treatment of femoropopliteal (FP) disease, including endovascular interventions (ENDOs) and bypass surgery (OPEN). There are limited data directly comparing ENDO and OPEN strategies for FP disease in chronic limb threatening ischaemia (CLTI). METHODS: Outcomes of patients in the Best Endovascular vs. Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial who underwent revascularisation for FP disease were examined. ENDO and OPEN were compared using single segment great saphenous vein (SSGSV) or alternative conduits (ACs). The primary outcome was major adverse limb event (MALE) or death; secondary outcomes included major amputation (MA); major re-intervention; amputation free survival; any re-intervention, MA, or death (RAD); and any re-intervention. RESULTS: Seven hundred and sixty-four patients underwent ENDO (378), OPEN with SSGSV (265), or OPEN with AC (121) procedures for FP disease. Patients had a mean age of 67 years; 66.6% were men, and 75.9% were White. Comorbidities included hypertension (85.5%), hyperlipidaemia (75.4%), diabetes mellitus (59.5%), smoking (47.2%), coronary artery disease (40.4%), and end-stage renal disease (7.6%); 68.4% of patients had tissue loss. Wound, Ischemia, and foot Infection (WIfI) stages were stage 1 (7.3%), stage 2 (35.2%), stage 3 (28.4%), and stage 4 (29.1%). TASC II classification of the FP disease was A and B (24.0%), C (25.4%), D (34.8%), or not scored (15.8%). Associated (untreated) infrapopliteal disease was present in 42.5%. ENDO treatments included plain balloon angioplasty (9.3%), drug coated balloons (32%), drug eluting stents (24.9%), bare metal stents (55.6%), stent grafts (17.5%), and atherectomy (11.1%). Cox models demonstrated superior MALE and death, MA, RAD, major re-intervention, and any re-intervention for OPEN SSGSV vs. ENDO. OPEN SSGSV also demonstrated superior freedom from MALE and death, and greater amputation free survival vs. OPEN AC. Presence of infrapopliteal disease, tissue loss, TASC classification, and diabetes mellitus were significant covariables. CONCLUSION: Open FP bypass with an SSGSV conduit provides the most effective revascularisation for patients with CLTI due to advanced FP disease.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Conte MS, Farber A, Liu IH, et al. Editor's Choice - Open versus Endovascular Revascularisation for Femoropopliteal Disease in Patients with Chronic Limb Threatening Ischaemia. Eur J Vasc Endovasc Surg. 2026. PMID: 41708051. doi:10.1016/j.ejvs.2026.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。